PRESCRIBING · PART D · 2024
Total Rx claims
82
Beneficiaries
—
Total drug cost
$305K
Distinct drugs
2
Brand share
100.0%
Top prescribed drugs
Bictegrav/Emtricit/Tenofov Ala50 claims
Abacavir/Dolutegravir/Lamivudi32 claims
QUALITY · MIPS · 2024
Final MIPS score
84.2
Quality
65.6
Cost
74.7
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.39%
Group
CROSS-REFERENCE